QMGAX
Price
$12.96
Change
-$0.13 (-0.99%)
Updated
Aug 25 closing price
Net Assets
52.8M
VTISX
Price
$162.01
Change
-$1.46 (-0.89%)
Updated
Aug 25 closing price
Net Assets
505.75B
Interact to see
Advertisement

QMGAX vs VTISX

Header iconQMGAX vs VTISX Comparison
Open Charts QMGAX vs VTISXBanner chart's image
Invesco Advantage International A
Price$12.96
Change-$0.13 (-0.99%)
VolumeN/A
Net Assets52.8M
Vanguard Total Intl Stock Idx Instl Sel
Price$162.01
Change-$1.46 (-0.89%)
VolumeN/A
Net Assets505.75B
QMGAX vs VTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QMGAX vs. VTISX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QMGAX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 506B vs. QMGAX (52.8M). QMGAX pays higher dividends than VTISX: QMGAX (3.80) vs VTISX (2.87). QMGAX was incepted earlier than VTISX: QMGAX (10 years) vs VTISX (9 years). QMGAX (1.94) is less costly to investors than VTISX (0.05). QMGAX is a more actively managed with annual turnover of: 156.00 vs. VTISX (3.00). QMGAX has a lower initial minimum investment than VTISX: QMGAX (1000) vs VTISX (3000000000). QMGAX annual gain was more profitable for investors over the last year : 18.29 vs. VTISX (15.09). VTISX return over 5 years is better than : 39.34 vs. QMGAX (27.58).
QMGAXVTISXQMGAX / VTISX
Total Expense Ratio1.180.052,511%
Annual Report Gross Expense Ratio1.940.054,128%
Fund Existence10 years9 years-
Gain YTD24.78622.804109%
Front Load6%N/A-
Min. Initial Investment100030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets52.8M506B0%
Annual Yield % from dividends3.802.87132%
Returns for 1 year18.2915.09121%
Returns for 3 years37.5542.9088%
Returns for 5 years27.5839.3470%
Returns for 10 years53.69N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.020.05
+5.66%
PharmaCyte Biotech
RAPP14.63-0.14
-0.95%
Rapport Therapeutics Inc.
GMAB24.31-0.34
-1.38%
Genmab A/S ADS
PAYO6.78-0.23
-3.28%
Payoneer Global
CSBR7.06-0.57
-7.47%
Champions Oncology